Defining Galactomannan Positivity in the Updated EORTC/MSGERC Consensus Definitions of Invasive Fungal Diseases

Toine Mercier1,2, Elio Castagnola3, Kieren A Marr4

  • 1Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

Insights

Updated guidelines for invasive fungal diseases now include galactomannan test cutoff values for diagnosing invasive aspergillosis. This article explains the rationale behind these new thresholds for better diagnostic accuracy.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Clinical Diagnostics

Background:

  • Recent revisions to the European Organisation for Research and Treatment of Cancer (EORTC)/Mycoses Study Group Education and Research Consortium (MSGERC) consensus definitions for invasive fungal diseases.
  • Inclusion of specific galactomannan test cutoff values for diagnosing probable invasive aspergillosis.

Purpose of the Study:

  • To provide a scientific rationale for the newly proposed galactomannan test thresholds.
  • To support the updated consensus definitions for invasive aspergillosis diagnosis.

Main Methods:

  • Review and analysis of galactomannan test characteristics.
  • Evaluation of test performance across diverse patient populations.
  • Assessment of test performance in various specimen types.

Main Results:

  • Proposed consensus cutoff values for the galactomannan assay.
  • Demonstration of the rationale supporting these thresholds based on test performance data.

Conclusions:

  • The updated galactomannan thresholds aid in the diagnosis of probable invasive aspergillosis.
  • Understanding the rationale behind these thresholds is crucial for accurate clinical application.

Related Concept Videos